new glp-1 drugs Eli Lilly to seek approval of weight-loss drug this year How GLP-1 medications are transforming

Verma S, Poulter NR, Bhatt DL et al (2018) Effects of liraglutide on cardiovascular outcomes in patients with type 2 diabetes mellitus with or without history of myocardial infarction or stroke

Not only is it important to know all the beneficial effects, but it also is important to know the potential negative effects, so patients can be counseled properly. The next steps would be to design a study to see the mechanism for improvement in cardiovascular health, he added

MEDVi works by prescribing personalized GLP-1 medication to support weight loss goals

The extraordinary case of the cancer drug Keytruda may offer insight into the potential road ahead for GLP-1s

Evaluations were at baseline 2.5 h, 24 h and 12 weeks (with additional blood sampling at 2 weeks)

In obese mice, VK2735 shows effects comparable to semaglutide, reducing body weight by up to 26.67% in 20 days